← Back to Search

EX for Methamphetamine Abuse

Phase < 1
Waitlist Available
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

Study Summary

This trial will look at the effects of exercise and health education on dopamine receptors in the brain, and how those receptors affect cognition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Striatal D2/3 Binding Potential (BPND) Upregulation
Secondary outcome measures
Decision making under risk and ambiguity
Memory
Inhibitory control - reversal learning
+10 more
Other outcome measures
Cocaine Craving
Methamphetamine Craving
Personality - impulsivity
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: EXExperimental Treatment1 Intervention
Participants in this arm of the study will be randomized in to the exercise intervention.
Group II: CONPlacebo Group1 Intervention
The control condition is a health-education intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EX
2009
Completed Early Phase 1
~130

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,528 Previous Clinical Trials
10,276,738 Total Patients Enrolled
8 Trials studying Methamphetamine Abuse
1,160 Patients Enrolled for Methamphetamine Abuse

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is the ideal subject for this clinical trial?

"This clinical trial is recruiting 90 individuals aged 18-65 who are struggling with methamphetamine addiction. Furthermore, all applicants must be right handed."

Answered by AI

Does the age criterion for this trial extend beyond sixty years?

"This research trial is accepting participants that have attained the age of majority but are yet to reach retirement age."

Answered by AI

Are there still openings for participants of this research?

"This trial, which was initially published on June 26th 2019 and last updated in September 16th 2022, is not currently enrolling patients. Nonetheless, there are 12 other ongoing studies that are actively recruiting participants."

Answered by AI

Who else is applying?

What state do they live in?
California
How old are they?
18 - 65
What site did they apply to?
University of California Los Angeles
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I have had some major depression as a result of using methanefedamine. I have had some major depression and parenoia as a result of using methanefedamine.
PatientReceived 2+ prior treatments
I have had some major depression and pareanoia as a result of using methanefedamine.
PatientReceived 1 prior treatment
~19 spots leftby Apr 2025